BUZZ-West Pharma rises after raising annual forecasts

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

WST

0.00

** Shares of medical equipment maker West Pharmaceutical WST.N rise 7.3% to $384.5 premarket

** West Pharma now expects 2026 adjusted profit per share to be between $8.85 and $9.05, compared with its prior view of $8.40 to $8.75 per share

** Expects its annual sales to be in the range of $3.35 billion to $3.38 billion, up from its previous forecast of $3.295 billion to $3.35 billion

** WST reports Q2 adjusted profit of $2.37 per share, above analysts' estimates of $2.08 per share - LSEG data

** Its quarterly revenue came in at $872.3 million, above analysts' expectations of $838.6 million

** As of last close, stock was up 30.3% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.